Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: Retrospective cohort study and time-series intervention analysis

BMJ Open

Volumn 2, Issue 3, 2012, Pages

  Lawes, Timothy ^a   Edwards, Becky ^b   López Lozano, José Maria ^c   Gould, Ian ^b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c HOSPITAL VEGA BAJA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; PSEUDOMONIC ACID;

ADULT; ARTICLE; BACTERIAL LOAD; BACTERIUM ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION CONTROL; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY; SCREENING; STAPHYLOCOCCAL BACTEREMIA; TEACHING HOSPITAL; TIME SERIES ANALYSIS; UNITED KINGDOM;

EID: 84863654433     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000797     Document Type: Article

References (71)

1. Allegranzi B, Bagheri Nejad S, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011;377:228-41.
2. Wilson J, Elgohari S, Livermore DM, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2011;17:451-8.
3. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006;333:281-6.
4. Blot SI, Vandewoude KH, Hoste EA, et al. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162:2229-35. (Pubitemid 35231593)
5. de Kraker ME, Davey PG, Grundmann H; On behalf of the BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011;8:e1001104.
6. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005;56:455-62. (Pubitemid 41264120)
7. Clements A, Halton K, Graves N, et al. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis 2008;8:427-34. (Pubitemid 351863737)
8. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009;64(Suppl 1):i11-17.
9. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011;66(Suppl 2):ii41-7.
10. Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control. J Antimicrob Chemother 2011;66:2685-8.
11. Health Protection Agency. Voluntary Reporting of Staphylococcus aureus Bacteraemia in England, Wales and Northern Ireland, 2010. London: Health Protection Agency, 2011.
12. Health Protection Scotland. SNBTS Annual Infection Control Report: April 2010 to March 2011. Edinburgh: Health Protection Scotland, 2011.
13. Shurland S, Zhan M, Bradham DD, et al. Comparison of mortality risk associated with bacteremia due to Methicillin-Resistant and Methicillin- Susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28:273-9. (Pubitemid 46480725)
14. Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008;46:799-806.
15. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001;175:264-7. (Pubitemid 32851061)
16. Wolkewitz M, Frank U, Philips G, et al. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus:a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 2011;66:381-6.
17. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin Infect Dis 2003;36:53-9. (Pubitemid 36099097)
18. Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteraemia on patient outcomes: mortality, length of stay, and hospital Charges. Infect Control Hosp Epidemiol 2005;26:166-74. (Pubitemid 40445022)
19. NHS Scotland. HEAT Targets Due for Delivery in 2009/10: Summary of Performance. Edinburgh: NHS Scotland Performance and Business Management, 2011.
20. Paul J. Surveillance and management of all types of Staphylococcus aureus bacteraemia. BMJ 2006;333:269.
21. Mostofsky E, Lipsitch M, Regev-Yochay G. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S.aureus? J Antimicrob Chemother 2011;66:2199-214.
22. Cooper BS, Stone SP, Kibbler CC, et al. Systematic review of isolation measures in the hospital management of methicillin resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 2003;7:191-4.
23. Wilcox MH. Screening for MRSA. BMJ 2008;336:899-900.
24. Loeb M, Main C, Walker-Dilks C, et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003;(4):CD003340.
25. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008;46:1717-25. (Pubitemid 351706769)
26. Clancy M, Graepler A, Wilson M, et al. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006;27:1009-17. (Pubitemid 44670975)
27. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971-8. (Pubitemid 44631095)
28. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419-30.
29. Reilly JS, Stewart S, Christie P, et al. Universal screening for methicillin resistant Staphyloccocus aureus: interim results from the NHS Scotland pathfinder project. J Hosp Infect 2010;74:35-41.
30. Health Protection Scotland; National Services Scotland. NHS Scotland MRSA Screening Pathfinder Programme Final Report Volume 1: An Investigation of the Clinical Effectiveness of MRSA Screening [Report]. Glasgow: Health Protection Scotland, 2011.
31. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007;7:282-8. (Pubitemid 46420801)
32. Chen YC, Sheng WH, Wang JT, et al. Effectiveness and limitations of hand hygiene promotion on decreasing healthcare-associated infections. PLoS One 2011;6:e27163.
33. Sroka S, Gastmeier P, Meyer E. Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature. J Hosp Infect 2010;74:204-11.
34. Kaier K, Hagist C, Frank U, et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:346-53.
35. Aldeyab MA, Monnet DL, López-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008;62:593-600.
36. Monnet DL, Mackenzie FJ, Lopez-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004;10:1432-41. (Pubitemid 39014157)
37. Taconnelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008;61:26-38.
38. Shardell M, Harris AD, El-Kamary SS, et al. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007;45:901-7. (Pubitemid 47580386)
39. Pankratz A. Forecasting with Dynamic Regression Models. New York (NY): Wiley, 1991.
40. Liu LM, Hudak GB. Forecasting and Time Series Analysis Using the SCA Statistical System. Chicago (IL): Scientific Computing Associates, 1994.
41. Thwaites GE; United Kingdom clinical infection research group (UKCIRG). The management of Staphylococcus aureus bacteraemia in the United Kingdom and Vietnam: a multi-centre evaluation. PLoS One 2010;5:e14170.
42. Edwards B, Milne K, Lawes T, et al. Is Vancomycin MIC 'creep'method dependent? Analysis of methicillin-resistant S. aureus (MRSA) susceptibility trends in blood isolates from North East Scotland, 2006-10. J Clin Microbiol 2012;50:318-25.
43. Hunt AC, Edwards B, Girvan EK, et al. Methicillin-resistant Staphylococcus aureus in northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns. J Clin Microbiol 2011;49:1975-8.
44. Jeyaratnam D, Whitty CJM, Phillips K, et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008;336:927-30. (Pubitemid 351632018)
45. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299:1149-57. (Pubitemid 351398429)
46. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409-18. (Pubitemid 351665440)
47. Seybold U, Schubert S, Bogner JR, et al. Staphylococcus aureus infection following nasal colonisation: an approach to rapid risk stratification in a university healthcare system. J Hosp Infect 2011;79:297-301.
48. Honda H, Krauss MJ, Coopersmith CM, et al. Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter? Infect Control Hosp Epidemiol 2010;31:584-91.
49. Harbarth S, Hawkey PM, Tenover F, et al. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2011;37:110-17.
50. Hacek DM, Paule SM, Thomson RB, et al. Implementation of a Universal Admission Surveillance and Decolonisation Program for Methicillin-Resistant Staphylococcus aureus (MRSA) reduces the number of MRSA and total number of S. aureus isolates reported by the clinical laboratory. J Clin Microbiol 2009;47:3749-52.
51. Leonhardt KK, Yakusheva O, Phelan D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol 2011;32:797-803.
52. Hardy K, Price C, Szczepura A, et al. Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect 2009;16:333-9.
53. Walker S, Peto TE, O'Conner L, et al. Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study. PLoS One 2008;3:e2378.
54. Reilly JS, Stewart S, Christie P, et al. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. J Hosp Infect 2012;80:31-5.
55. MacKenzie FM, Lopez-Lozano JM, Monnet DL, et al. Temporal relationship between prevalence of meticillin-resistant Staphylococcus aureus (MRSA) in one hospital and prevalence of MRSA in the surrounding community: a time-series analysis. J Hosp Infect 2007;67:225-31. (Pubitemid 350028512)
56. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9. (Pubitemid 36143409)
57. Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. BMJ 2005;331:992-7.
58. van Velzen EV, Reilly JS, Kavanagh K, et al. A retrospective cohort study into acquisition of MRSA and associated risk factors after implementation of universal screening in Scottish hospitals. Infect Control Hosp Epidemiol 2011;32:889-96.
59. Robotham JV, Graves N, Cookson BD, et al. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation. BMJ 2011;343:d5694.
60. Murthy A, De Angelis G, Pittet D, et al. Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect 2010;16:1747-53.
61. Hubben G, Bootsma M, Luteijn M, et al. Modelling the costs and effects of selective and universal hospital admission screening for Methicillin resistant Staphylococcus aureus. PloS One 2011;6:e14783.
62. Lee BY, Bailey RR, Smith KJ, et al. Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol 2010;31:598-606.
63. Collins J, Raza M, Ford M, et al. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme. J Hosp Infect 2011;78:81-5.
64. Kirkland KB. Taking off the gloves: towards a less dogmatic approach to the use of contact isolation. Clin Infect Dis 2009;48:766-71.
65. Health Protection Scotland. Protocol for CRA MRSA Screening National Rollout in Scotland. Glasgow: Health Protection Scotland, 2011.
66. Morgan DJ, Day HR, Furuno JP, et al. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission. Infect Control Hosp Epidemiol 2010;31:1230-5.
67. Gould IM, Reilly J, Bunyan D, et al. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control. Clin Microbiol Infect 2010;16:1721-8.
68. Hetem DJ, de Ruiter SC, Buiting AG, et al. Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis. Medicine 2011;90:284-8.
69. Lucet JC, Regnier B. Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus? Clin Infect Dis 2010;51:585-90.
70. Gwizdala RA, Miller M, Bhat M, et al. Staphylococcus aureus colonization and infection among drug users: identification of hidden networks. Am J Public Health 2011;101:1268-76.
71. Saxena AK, Panhotra BR, Venkateshappa CK, et al. The impact of nasal carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA & MSSA) on vascular access-related septiceamia among patients with type-II diabetes on dialysis. Ren Fail 2002;24:763-77. (Pubitemid 35404069)